Covid-19 vs. BCG Universal Immunization: Statistical Significance in the Early Phase of the Pandemics
Abstract
A possible correlation between the impact of Covid-19 and universal immunization program against tuberculosis with Bacillus Calmette-Guérin (BCG) vaccine was suggested previously, based on apparent correlation between lower impact of the epidemics and a record of national BCG immunization program. In this work a time-adjusted dataset of Covid-19 statistical data by national and subnational health jurisdictions at the time point of six months after the local arrival of the epidemics was used to perform a statistical analysis of the significance of the correlation hypothesis between universal BCG immunization and a milder early phase Covid-19 scenario. With the data accumulated up to the point of the analysis, the significance of the correlation hypothesis was evaluated both qualitatively and quantitatively with the conclusion that it has achieved statistically significant level of confidence. The conclusions of this research can be used in development of epidemiological policy as well as the rationale to investigate the origin and mechanisms of a broad immunity protection that can be associated with an early-age exposure to BCG vaccine.
Doi: 10.28991/SciMedJ-2021-03-SI-8
Full Text: PDF
Keywords
References
Miller, A., Reandelar, M. J., Fasciglione, K., Roumenova, V., Li, Y., & Otazu, G. H. (2020). Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. medRxiv. doi:10.1101/2020.03.24.20042937
Escobar, L. E., Molina-Cruz, A., & Barillas-Mury, C. (2020). BCG Vaccine Protection from Severe Coronavirus Disease 2019 (COVID19). Proceedings of the National Academy of Sciences, 117(44), 27741-27742. doi:10.1101/2020.05.05.20091975.
Sharma, A., Kumar Sharma, S., Shi, Y., Bucci, E., Carafoli, E., Melino, G., … Das, G. (2020). BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic? Cell Death & Disease, 11(7), 1-10. doi:10.1038/s41419-020-2720-9.
Yitbarek, K., Abraham, G., Girma, T., Tilahun, T., & Woldie, M. (2020). The effect of Bacillus Calmette–Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Vaccine, 38(41), 6374–6380. doi:10.1016/j.vaccine.2020.08.018.
Dolgikh S. (2020). Further evidence of a possible correlation between the severity of Covid-19 and BCG immunization. Journal of Infectious Diseases and Epidemiology, 6(2). doi:10.23937/2474-3658/1510120.
Gursel, M., & Gursel, I. (2020). Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS-CoV-2 pandemic? Allergy, 75(7), 1815-1819. doi:10.1111/all.14345.
Berg M.K., Yu Q, Salvador C.E., Melani I. & Kitayama S. (2020). Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19. Science Advances, 6(32) eabc1463. doi:10.1126/sciadv.abc1463.
Meena, J., Yadav, A., & Kumar, J. (2020). BCG Vaccination Policy and Protection against COVID-19. The Indian Journal of Pediatrics, 87(9), 749. doi:10.1007/s12098-020-03371-3.
Paredes J.A., Garduno V. & Torres J. (2020). COVID-19 Related Mortality: Is the BCG Vaccine Truly Effective? medRxiv. doi:10.1101/ 2020.05.01.20087411.
Szigeti R., Kellermayer D. & Kellermayer R. (2020). BCG protects against COVID-19? A word of caution. medRxiv. doi:10.1101/2020.05.01.20087411.
Smith S.G., Kleinnijenhuis J., Netea M.G. & Dockrell H.M. (2017). Whole blood profiling of bacillus Calmette–Guérin-induced trained innate immunity in infants identifies epidermal growth factor, IL-6, platelet-derived growth factor-AB/BB, and natural killer cell activation. Frontiers in Immunology 8, 644. doi:10.3389/fimmu.2017.00644.
Brandau S. and Suttmann H. (2007). Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomedicine and Pharmacotherapy, 61 (6), 299–30. doi:10.1016/j.biopha.2007.05.004.
Roy P., Vekemans J., Clark A., Sanderson C., Harris R.C. & White R.G. (2019). Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study, The Lancet, 7(12) e1655-1663 (2019). doi:10.1016/s2214-109x(19)30444-9.
Zwerling A., Behr M.A., Verma A., Brewer T.F., Menzies D., Pai M. (2011). The BCG World Atlas: a database of global BCG vaccination policies and practices. PLOS Medicine. doi:10.1371/journal.pmed.1001012.
BCG World Atlas. Available online: http://www.bcgatlas.org (accessed on September 2020).
Coronavirus map Google. Available online: https://www.google.com/covid19-map (accessed on September 2020).
Canada Covid-19 situation update. Available online: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection.html?topic=tilelink (accessed on September 2020).
New York City Covid-19 Updates. Available online: https://www1.nyc.gov/site/doh/covid/covid-19-data.page (accessed on September 2020).
Taiwan Center for Disease Control Covid-19 information. Available online: https://www.cdc.gov.tw/En/Category/ListContent/bg0g_VU_Ysrgkes_KRUDgQ (accessed on September 2020).
National Tuberculosis Advisory Committee. (2006). The BCG vaccine: information and recommendations for use in Australia. Communicable Disease Intelligence 30(1) 109-15.
WHO immunization estimates, BCG by country. Available online: https://apps.who.int/gho/data/node.main.A830 (accessed on September 2020).
Health Ministry of Ukraine. Available online: https://www.kmu.gov.ua/en/news/v-ukrayini-zareyestrovanij-vipadok-zahvoryuvannya-na-covid-19-moz (accessed on September 2020).
Brook, B., Harbeson, D. J., Shannon, C. P., Cai, B., He, D., … Ben-Othman, R. (2020). BCG vaccination–induced emergency granulopoiesis provides rapid protection from neonatal sepsis. Science Translational Medicine, 12(542), eaax4517. doi:10.1126/scitranslmed.aax4517.
Channappanavar R, Fett C, Mack M, Ten Eyck P.P, Meyerholz D.K & Perlman S. (2017). Sex-based differences in susceptibility to Severe Acute Respiratory Syndrome coronavirus infection. Journal of Immunology, 198(10), 4046–4053. doi:10.4049/jimmunol.1601896.
Covián A.R-D., Bueno S.M & Kalergis A.M. (2020). Could BCG vaccination induce protective trained immunity for SARS-CoV-2? Frontiers in Immunology, 11. doi:10.3389/fimmu.2020.00970.
Sinha S. (2020). Possible role of BCG-induced trained immunity to reduce the prevalence and severity of Covid-19 in high-risk population. Journal of Infectious Diseases and Travel Medicine, 4(S1). doi:10.23880/jidtm-16000s1-005.
Freedman D. (2005). Statistical Models: Theory and Practice. Cambridge University Press.
Montgomery D.C. and Runger G.C. (2014). Applied Statistics and Probability for Engineers (6th Ed.). Wiley.
Zeka A., Tobias A., Leonardi G., Bianchi F., Lauriola P. et al. (2020). Responding to COVID-19 requires strong epidemiological evidence of environmental and societal determining factors. The Lancet Planetary Health, 4(9), e375-376. doi:10.1016/s2542-5196(20)30169-8.
Rousseau M.C., Conus F., Ka K., El-Zein M., Parent E.-M. & Menzies D. (2017). Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956–1974. Vaccine 35(36), 4777–4784. doi:10.1016/j.vaccine.2017.06.064.
Sweeney E., Dahly D., Seddiq N., Corcoran G., Horgan M. & Sadlier C. (2019). Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland. BMC Infectious Diseases, 19(1), 397. doi:10.1186/s12879-019-4026-z.
France Loi n° 50-7 du 5 janvier 1950, (1950).
DOI: 10.28991/SciMedJ-2021-03-SI-8
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Serge Dolgikh
